Cadmium, arsenic, selenium and iron- Implications for tumor progression in breast cancer

被引：57
|
作者：
Jablonska, E. [1 ]
Socha, K. [2 ]
Reszka, E. [1 ]
Wieczorek, E. [1 ]
Skokowski, J. [3 ,4 ,5 ]
Kalinowski, L. [3 ,4 ,5 ]
Fendler, W. [6 ]
Seroczynska, B. [3 ,4 ,5 ]
Wozniak, M. [3 ,4 ,5 ]
Borawska, M. H. [2 ]
Wasowicz, W. [7 ]
机构：
[1] Nofer Inst Occupat Med, Dept Mol Genet & Epigenet, Teresy 8 Str, PL-91348 Lodz, Poland
[2] Med Univ Bialystok, Dept Bromatol, A Mickiewicza 2D Str, PL-15222 Bialystok, Poland
[3] Med Univ Gdansk, Dept Surg Oncol, M Smoluchowskiego 17 Str, PL-80952 Gdansk, Poland
[4] Dept Med Lab Diagnost, Debinki 7, PL-80211 Gdansk, Poland
[5] Bank Frozen Tissues & Genet Specimens, Debinki 7, PL-80211 Gdansk, Poland
[6] Med Univ Lodz, Dept Pediat Oncol Hematol & Diabetol, Sporna 35-50 Str, PL-91738 Lodz, Poland
[7] Nofer Inst Occupat Med, Dept Biol & Environm Monitoring, Teresy 8 Str, PL-91348 Lodz, Poland
来源：
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY | 2017年 / 53卷
关键词：
Cadmium; Arsenic; Selenium; Iron; Breast cancer; ESTROGEN-RECEPTOR; UPDATED METAANALYSIS; URINARY CADMIUM; RISK; GROWTH; ASSOCIATION; EXPOSURE; CELLS; INHIBITION; EXPRESSION;
D O I：
10.1016/j.etap.2017.05.014
中图分类号：
X [环境科学、安全科学];
学科分类号：
08 ; 0830 ;
摘要：
The aim of this study was to determine Cd (cadmium) and As (arsenic) contents in human breast cancer tissues, investigate their interactions with Se (selenium) and Fe (iron), and assess their further implications for tumor progression. Metal contents were determined in 42 tissue sets (tumor and adjacent tissue) collected from 42 women diagnosed with primary breast cancer. Analytical methods included AAS and ICP-MS techniques. Significantly higher contents of Cd (p = 0.0003), Se (p < 0.0001) and Fe (p = 0.0441) whereas significantly lower content of As (p < 0.0001) were observed in tumors as compared to adjacent tissues. There was a significant positive correlation between Cd and As contents in tumor tissue. However, only Cd was significantly associated with histological type of tumor, its size, grading and progesterone receptor status. This study support the role of Cd in breast cancer risk and progression. The possible link between As exposure and breast cancer is still not clear.
引用
收藏
页码：151 / 157
页数：7
相关论文
共 50 条
  • [41] Upregulated EBI3 Correlates with Poor Outcome and Tumor Progression in Breast Cancer
    Jiang, Jinyan
    Liu, Xiangyong
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (03) : 111 - 115
  • [42] The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies
    Zarrilli, Giovanni
    Businello, Gianluca
    Dieci, Maria Vittoria
    Paccagnella, Silvia
    Carraro, Valentina
    Cappellesso, Rocco
    Miglietta, Federica
    Griguolo, Gaia
    Guarneri, Valentina
    Lo Mele, Marcello
    Fassan, Matteo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 23
  • [43] Calcium-Binding Protein S100P Promotes Tumor Progression but Enhances Chemosensitivity in Breast Cancer
    Cong, Yizi
    Cui, Yuxin
    Wang, Suxia
    Jiang, Lei
    Cao, Jianqiao
    Zhu, Shiguang
    Birkin, Emily
    Lane, Jane
    Ruge, Fiona
    Jiang, Wen G.
    Qiao, Guangdong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] Tumor Microenvironment Modulation by Tumor-Associated Macrophages: Implications for Neoadjuvant Chemotherapy Response in Breast Cancer
    Oner, Gizem
    Praet, Marleen Marguerite
    Stoop, Hans
    Devi, Gayathri R.
    Canturk, Nuh Zafer
    Altintas, Sevilay
    Van Berckelaer, Christophe
    Berneman, Zwi
    Tjalma, Wiebren
    Koljenovic, Senada
    Dam, Peter A. van
    BREAST CANCER-TARGETS AND THERAPY, 2025, 17 : 211 - 224
  • [45] Iron- and erythropoietin-resistant anemia in a spontaneous breast cancer mouse model
    Bregolat, Nuria Fabregas
    Ruetten, Maja
    Da Silva, Milene Costa
    Aboouf, Mostafa A.
    Ademi, Hyrije
    von Buren, Nadine
    Armbruster, Julia
    Stirn, Martina
    Altamura, Sandro
    Marques, Oriana
    Rodriguez, Josep M. Monne
    Samillan, Victor J.
    Singh, Rashim Pal
    Wielockx, Ben
    Muckenthaler, Martina U.
    Gassmann, Max
    Thiersch, Markus
    HAEMATOLOGICA, 2022, 107 (10) : 2454 - 2465
  • [46] Biological progression of breast cancer and clinical implications
    Vici, P.
    Sergi, D.
    Pizzuti, L.
    Vincenzoni, C.
    Baiocco, E.
    Mancini, E.
    Lopez, M.
    Vizza, E.
    Lauro, L. D.
    CLINICA TERAPEUTICA, 2011, 162 (04): : 297 - 299
  • [47] The Tumor Immune Microenvironment in Breast Cancer Progression
    Fjortoft, Marit Otterlei
    Huse, Kanutte
    Rye, Inga Hansine
    ACTA ONCOLOGICA, 2024, 63 : 359 - 367
  • [48] Arsenic-induced BRCA1 CpG promoter methylation is associated with the downregulation of ER and resistance to tamoxifen in MCF7 breast cancer cells and mouse mammary tumor xenografts
    Selmin, Ornella I.
    Donovan, Micah G.
    Skovan, Bethany
    Paine-Murieta, Gillian D.
    Romagnolo, Donato F.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 54 (03) : 869 - 878
  • [49] The interleukin-1 family of cytokines and receptors in human breast cancer: Implications for tumor progression
    Pantschenko, AG
    Pushkar, I
    Anderson, KH
    Wang, YP
    Miller, LJ
    Kurtzman, SH
    Barrows, G
    Kreutzer, DL
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (02) : 269 - 284
  • [50] Tumor-associated macrophages: An important player in breast cancer progression
    Huang, Xinqun
    Cao, Jingsong
    Zu, Xuyu
    THORACIC CANCER, 2022, 13 (03) : 269 - 276
12345